Requirements of Propofol With Target Controlled Infusions for Supraglottic Airway Devices

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

to evaluate and compare the effect-site concentration of propofol with the TCI system for second-generation SGA device insertion between the I-gel™, Supreme™, ProSeal™ and Laryngeal Tube Suction II™.

to determine the hemodynamic changes during insertion of supraglottic devices in patients undergoing elective surgery and any complications after device insertion.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Prince of Songkla University
• Treatments: Propofol

Criteria

Inclusion Criteria:

• ASA physical status I-III patients.

• Patients 18-70 years old .

• Patients scheduled for general anesthesia for elective non-cardiac surgery with SGA devices.

Exclusion Criteria:

• Adults with a potentially difficult airway (cervical spine disease, Mallampati classification IV, or a mouth opening less than 2.5 cm.).

• Adults with reactive airway disease.

• Adults with signs of respiratory infection or a plan to remain intubated were excluded from the study.

• Excluded patients who had a risk of gastric aspiration or morbid obesity (body mass index > 35 kg/m2).